Pliant Therapeutics, Inc.
PLRX
$1.48
$0.010.68%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -49.73M | -57.76M | -55.85M | -46.96M | -41.11M |
| Total Depreciation and Amortization | 458.00K | 532.00K | 622.00K | 513.00K | 464.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.79M | 10.71M | 11.65M | 11.44M | 14.93M |
| Change in Net Operating Assets | -8.18M | 14.25M | -1.71M | 4.73M | 609.00K |
| Cash from Operations | -47.66M | -32.27M | -45.30M | -30.27M | -25.10M |
| Capital Expenditure | -209.00K | -896.00K | -1.25M | -1.49M | -61.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.34M | 31.86M | 11.95M | 61.04M | 31.98M |
| Cash from Investing | 39.13M | 30.96M | 10.70M | 59.55M | 31.92M |
| Total Debt Issued | 1.00K | 0.00 | 0.00 | 19.91M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 101.00K | 543.00K | 684.00K | 1.88M | 232.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -13.00K |
| Cash from Financing | 102.00K | 543.00K | 684.00K | 21.79M | 219.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.43M | -770.00K | -33.91M | 51.06M | 7.04M |